SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-017481
Filing Date
2018-06-20
Accepted
2018-06-20 20:25:08
Documents
2
Period of Report
2018-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2702
2 EX-24 DOCUMENT attachment1.htm EX-24 3238
  Complete submission text file 0000899243-18-017481.txt   7339
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XERIS PHARMACEUTICALS 180 N. LASALLE ST., STE. 1800 CHICAGO IL 60601
Business Address
HALKUFF DAWN (Reporting) CIK: 0001743658 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38536 | Film No.: 18910690